Omvoh is a medicine used to treat adults with: - ulcerative colitis, a disease that causes inflammation of the large intestine, leading to ulceration and bleeding. - Crohn’s disease, an inflammatory disease affecting the gut. Omvoh is used to treat moderately to severely active ulcerative colitis and Crohn’s disease when conventional therapy or biological treatments have not worked well enough, have stopped working, or have caused unacceptable side effects. Omvoh contains the active substance mirikizumab.
Therapeutic Indication
### Therapeutic indication Omvoh is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.
Therapeutic Area (MeSH)
ATC Code
L04AC
ATC Item
白细胞介素抑制剂
Pharmacotherapeutic Group
Immunosuppressants
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| Mirikizumab | N/A | Mirikizumab |
EMA Name
Omvoh
Medicine Name
Omvoh
Aliases
N/ANo risk management plan link.
